3737 — Zhongzhi Pharmaceutical Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$1.04bn
- HK$1.05bn
- CNY2.05bn
- 98
- 88
- 34
- 89
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 156 | 167 | 61.8 | 131 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -14.8 | -20.1 | 29.8 | -11.3 | — |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -36.8 | -154 | 1.71 | 68.8 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 168 | 93.2 | 178 | 285 | — |
Capital Expenditures | -74.9 | -126 | -188 | -89.1 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 18.3 | -124 | 51.9 | 103 | — |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -56.6 | -250 | -136 | 13.4 | — |
Financing Cash Flow Items | — | 1.5 | 0.6 | 0.02 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -64.9 | -71.9 | -40.8 | -68.1 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 47.6 | -229 | 2.35 | 228 | — |